Scientists have identified the presence of cancer-suppressing cells in pancreatic cancer

A research team led by Nagoya University has revealed that cells containing a protein called Meflin have a role in restraining the progression of pancreatic cancer, a type of cancer that is hard to treat with traditional anti-cancer drugs. The team has also shown that cancer progression can be limited by artificially increasing the amount of this protein in the cells. These findings could lead to the development of new therapies against pancreatic cancer. This study was published online in Cancer Research on Aug 22, 2019.